EPIVAX ONCOLOGY
Live / Registered — Registered (as of 24 Dec 2019)
What this means for you
Registered since 24 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87294376
- Registration number
- 5944493
- Mark type
- Stylized text
- Filed
- 09 Jan 2017
- Published for opposition
- 12 Sept 2017
- Registered
- 24 Dec 2019
- Attorney of record
- Cheryl A. Clarkin
Goods and services
- Class 042 — Scientific and technological services: Research and development of personalized cancer vaccines; medical research in the field of cancer, namely, processing cancer and normal protein sets and identifying high-quality patient specific neo-antigens
- Class 044 — Medical, beauty and agricultural services: Medical analysis services for the treatment of cancer, namely, processing of cancer and normal protein sets and identifying high-quality patient specific neo-antigens
Owner
- EPIVAX THERAPEUTICS, INC., PROVIDENCE, RI, US
- EPIVAX ONCOLOGY, INC., Providence, RI, US
- EPIVAX ONCOLOGY, INC., Providence, RI, US
- EpiVax, Inc., Providence, RI, US
- EpiVax, Inc., Providence, RI, US
Prosecution history
- 24 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 21 Sept 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Sept 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Sept 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Mar 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 16 Nov 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Nov 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 12 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Oct 2019 — USE AMENDMENT FILED
- 12 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Oct 2019 — TEAS STATEMENT OF USE RECEIVED
- 30 Oct 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Oct 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 12 Jul 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED